New And Special Drugs
-
Blenrep (Belantamab Mafodotin) – Multiple Myeloma | HongKong DengYue Medicine
-
Hyrnuo (Sevabertinib) – NSCLC | HongKong DengYue Medicine
-
Foundayo(Orforglipron) – Obesity/Overweight | HongKong DengYue Medicine
-
Exdensur (Depemokimab) – Eosinophilic Asthma | HongKong DengYue Medicine
-
Zometa (Zoledronic Acid) – HCM | HongKong DengYue Medicine
-
Taltz (Ixekizumab) – Plaque Psoriasis | HongKong DengYue Medicine
-
Megace (Megestrol Acetate) – Anorexia | HongKong DengYue Medicine
-
Adempas (Riociguat) – CTEPH/PAH | HongKong DengYue Medicine
What Can We Offer You?
Generic drugs
Dedicated to providing high-quality, affordable medicines around the world
Vitamins and Supplements
A balanced diet by addressing different deficiencies with the right dosage
brand name medicines
DengYue Medicine as China Drug Import and Export Wholesaler, fills the gap between quality and quantity by adding some affordability
Fast-moving consumer goods
Stock a full range of products from sanitary napkins to foot care creams for your daily needs
non-prescription drugs
Flagship OTC brand - approved and accepted by global standards
Medical supplies and auxiliary supplies
Explore continually updated supplies, diagnostic equipment and essential tools
News
HongKong DengYue Medicine Wholesaler focus on medical trends and obtain new drug directions.
ABSK061 Achondroplasia Orphan Drug Designation: Abbisko Therapeutics Advances Targeted Therapy
The ABSK061 achondroplasia orphan drug designation marks an important regulatory milestone in the development of targeted therapies for rare genetic skeletal disorders. Developed by Abbisko
Gene Therapy for Beta Thalassemia: Can CRISPR and Gene Addition Achieve Transfusion Independence?
For patients living with transfusion-dependent beta thalassemia (TDT), lifelong blood transfusions have long been the standard of care. While effective in maintaining hemoglobin levels, this
ADC Drugs by Target (2026 Update): Full List of Approved ADCs, Pipeline and Trends
Antibody-drug conjugates (ADCs) are one of the fastest-growing classes of therapies in precision oncology. In this guide to adc drugs by target, we provide a
China Generic Drug Market Trends 2026: Opportunities After Blockbuster Drug Patent Expiry
As global drug patents continue to expire, the China Generic Drug Market Trends 2026 indicate that the industry is entering a new cycle of competition
What Are the Signs of Liver Cancer Getting Worse? Symptoms of Advanced Liver Cancer
Liver cancer is one of the most serious and life-threatening cancers worldwide. According to the International Agency for Research on Cancer (IARC), liver cancer remains
Colorectal Cancer Treatment Options in China: Targeted Therapy, Immunotherapy and Innovative Drugs
Colorectal cancer (CRC) is one of the most common malignant tumors worldwide and remains a leading cause of cancer incidence and mortality, according to the
11 New Cancer Drugs Approved: Breakthroughs in Lung Cancer, Breast Cancer and Prostate Cancer Treatment
In February 2026, several new cancer drugs approved by global regulatory authorities marked significant progress in oncology treatment. These approvals came from organizations including China’s
NMPA Approved Drugs List – February 2026: 3 Innovative Drugs Approved in China
According to the National Medical Products Administration (NMPA), three innovative drugs were approved for marketing in China in February 2026. These newly added entries to
Fast And Safe Delivery
Global Transportation Express
Temperature-controlled Transport
Safe Transportation, GDP Compliant
